Charlotte Fribert

Company: Toleranzia AB

Job title: CEO

Seminars:

Tackling Toxicity Studies & Moving Lead Candidates to the Clinic for Myasthenia Gravis 3:45 pm

Highlighting the unique safety risks of the different antigen-specific approaches Discussing the toxicity studies for lead candidates to accelerate to the clinic Showcasing the data from toxicity studies in tolerance for autoimmune diseases Divulging regulatory discussions to illuminate progressing the tolerance landscape and approaches forwardRead more

day: Conference Day One